Search filters

Warteck Invest completes Capital Increase

VISCHER advises on the capital increase of Warteck Invest AG as transaction counsel. Warteck Invest is one of the oldest real estate companies listed on the SIX Swiss Exchange and is focusing on residential and business properties...

Kuros Biosciences enters convertible bond agreement

Kuros Biosciences AG (Kuros) entered into a convertible bond financing agreement with Nice & Green SA for up to a maximum of CHF 5 million. The facility is provided by Nice & Green SA (N&G), a private Swiss company which...

wefox Group raises USD 125 million in B round

wefox Group, the Berlin-based insurtech firm with headquarter in Zurich has successfully raised USD 125 million for its series B round. The USD 125 million investment is the largest series B round for an insurtech company...

New shareholder structure for Alpiq

VISCHER AG has advised the minority shareholder EBL (Genossenschaft Elektra Baselland) with regard to the new shareholder structure of Alpiq. The VISCHER team comprised David Jenny (Partner, Corporate/M&A), Stefan Grieder...

Freezing order: leading case Swiss Federal Court

In a leading case on 3 April 2019, the Swiss Federal Supreme Court ruled that improper novas, i.e. facts that arose before the decision of the first instance, are admissible in attachment opposition proceedings before the second...

NUMAB在中国达成许可和发展协议

中国苏州,瑞士苏黎世,2019年5月2日 - 基石药业(苏州)有限公司( 下称“基石药业”,香港联交所代码:2616)和瑞士Numab Therapeutics AG公司 (下称“Numab” )今天宣布,双方就候选药物ND021的开发和商业化达成一项独家区域性授权合作协议。ND021是一种针对PD-L1,4-1BB和人血清蛋白(HSA)的单价三特异性抗体片断分子,有成为同类最佳药物的潜力。

根据协议,基石药业将为ND021的研发提供资金直至完成初步Ib...

ALENTIS Therapeutics raises CHF 12.5m in Series A Financing

ALENTIS Therapeutics, a Swiss-French biotech company developing novel therapeutics in advanced liver disease and cancer, announced today the completion of a Series A financing of CHF 12.5 million. ALENTIS’ lead program is a...

Polyneuron raises CHF 22.5 million in a major Series A financing

Polyneuron Pharmaceuticals AG, a developer of a new class of biodegradable glycopolymers for the treatment of autoimmune diseases, today announced the closing of an oversubscribed CHF22.5 million Series A financing. The round was...

COTTA Group acquires 100% of the shares in Steinpol

COTTA Group, one of the leading upholstered furniture manufacturers in Europe, has acquired 100% of Quattro Mobili Kft, Kanizsa Trend Kft, both Hungary, Prolog Vertriebs GmbH, Germany, as well as Steinpol Central Services sp. z...

Cooperation between Spaeter/RUWA and Peikko

Spaeter AG, based in Basel, a Swiss wholesaler in the construction and ancillary construction sector, and its subsidiary RUWA-Drahtschweisswerk AG have entered into a comprehensive cooperation in Switzerland with the Finnish...

You are currently offline. Some pages or content may fail to load.